Journal
CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE
Volume 10, Issue 4, Pages 288-292Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/SPC.0000000000000242
Keywords
cancer cachexia; concurrent palliative care; long-term outcome; omega-3 fatty acids; perioperative period
Categories
Ask authors/readers for more resources
Purpose of reviewCachexia is a negative prognostic factor in cancer patients. The pathogenesis is related to a variable combination of reduced food intake and metabolic changes. However, whether nutritional support may contribute to effectively prevent and treat cachexia remains a debated issue.Recent findingsConsistent evidence demonstrates that anabolic windows of opportunity occur during the clinical trajectory of cancer patients. Also, the use of specific nutrients, namely omega-3 fatty acids, may enhance the efficacy of nutritional support when tumor-driven inflammatory response is high. Of greater interest, it is now becoming clearer that the use of nutritional support at key time points in the clinical journey of cancer patients (i.e., perioperative period) may extend its clinical benefits beyond those on nutritional status.SummaryNutritional support plays a role in managing cancer cachexia, when it is timely delivered, when it provides adequate amounts of calories and proteins, and when it is part of a concurrent palliative care approach. Specific nutrients, that is, omega-3 fatty acids, may help in those cancer patients with high-inflammatory response, and may also contribute to positively influence long-term clinical outcomes.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available